Emapgliflozin/Metformin not checked

Humanis Saglık Anonim Sirketi

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“1 tablet of Emapgliflozin/Metformin 12.5mg/1000mg Film-coated tablets”In the company’s words, NCT06450262 on ClinicalTrials.gov
Tested for
Type2diabetes
Main trialPhase 1
“Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Empagliflozin/ Metformin HCl 12.5mg/1000mg film-coated tablets (12.5mg Empagliflozin / 1000mg Metformin HCl) versus Synjardy® 12.5mg/1000mg film-coated tablets (12.5mg Empagliflozin/ 1000mg Metformin HCl) in healthy subjects under fed conditions.”In the company’s words, NCT06450262 on ClinicalTrials.gov
Copy of
Synjardy (Boehringer Ingelheim)Tested side by side with the original in NCT06450262

Other drugs for Type2diabetes

All 157 drugs for Type2diabetes

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Completed 16 Jan 2024 Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Emapgliflozin/Metformin

Following is part of Solo: you see every change to Emapgliflozin/Metformin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in